IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Journal of Immunotherapy

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

2.78

h-Index

2024-2025

 108

Rank

2024-2025

 3530

SJR

2024-2025

 1.203

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Journal of Immunotherapy
Abbreviation J. Immunother.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2); Immunology and Allergy (Q2)
h-index 108
Overall Rank/Ranking 3530
SCImago Journal Rank (SJR) 1.203
Impact Score 2.78
Publisher Lippincott Williams and Wilkins
Country United States
ISSN 15249557, 15374513
Best Quartile Q1
Coverage History 1991-2025




Aim and Scope


Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. JIT contains full-length articles, review articles, and short communications


About Journal of Immunotherapy


Journal of Immunotherapy is a journal covering the technologies/fields/categories related to Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2); Immunology and Allergy (Q2). It is published by Lippincott Williams and Wilkins. The overall rank of Journal of Immunotherapy is 3530. According to SCImago Journal Rank (SJR), this journal is ranked 1.203. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 108. The best quartile for this journal is Q1.

The ISSN of Journal of Immunotherapy journal is 15249557, 15374513. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Immunotherapy is cited by a total of 426 articles during the last 3 years (Preceding 2024).


Journal of Immunotherapy Impact IF 2024-2025


The Impact IF 2024 of Journal of Immunotherapy is 2.78, which is computed in 2025 as per its definition. Journal of Immunotherapy IF is decreased by a factor of 0.34 and approximate percentage change is -10.9% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Journal of Immunotherapy Impact IF 2025 Prediction


Impact IF 2024 of Journal of Immunotherapy is 2.78. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Journal of Immunotherapy. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 2.78
2023 3.12
2022 3.78
2021 4.63
2020 4.30
2019 4.17
2018 3.64
2017 4.23
2016 4.22
2015 4.20
2014 4.34

Journal of Immunotherapy h-index


  Table Setting

Journal of Immunotherapy has an h-index of 108. It means 108 articles of this journal have more than 108 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Journal of Immunotherapy ISSN


The ISSN of Journal of Immunotherapy is 15249557, 15374513. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Journal of Immunotherapy Rank and SCImago Journal Rank (SJR)


The overall rank of Journal of Immunotherapy is 3530. According to SCImago Journal Rank (SJR), this journal is ranked 1.203. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Journal of Immunotherapy by Year


Year SJR
2025/2026 Coming Soon
2024 1.203
2023 1.263
2022 1.397
2021 1.182
2020 1.805
2019 1.557
2018 1.568
2017 1.373
2016 2.110
2015 2.192
2014 1.730

Ranking of Journal of Immunotherapy by Year


Year Ranking
2025/2026 Coming Soon
2024 3530
2023 3020
2022 2394
2021 3134
2020 1624
2019 2081
2018 2077
2017 2679
2016 1252
2015 1225
2014 1810

Journal of Immunotherapy Publisher


Table Setting

Journal of Immunotherapy is published by Lippincott Williams and Wilkins. It's publishing house is located in United States. Coverage history of this journal is as following: 1991-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Journal of Immunotherapy is J. Immunother.. This abbreviation ('J. Immunother.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Journal of Immunotherapy


If your research field is/are related to Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2); Immunology and Allergy (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Journal of Immunotherapy?

Journal of Immunotherapy latest impact IF is 2.78. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.63 (2021) and 2.78 (2024), respectively, in the last 11 years. Moreover, its average IS is 3.95 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Journal of Immunotherapy?

The Journal of Immunotherapy has an SJR (SCImago Journal Rank) of 1.203, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 2.192 in 2015 and the lowest being 1.182 in 2021. Furthermore, the average SJR of the Journal of Immunotherapy over the previous 11-year period stands at 3.95.


What's the latest h-index of the Journal of Immunotherapy?

The latest h-index of the Journal of Immunotherapy is 108.


Who's the publisher of the Journal of Immunotherapy?

The Journal of Immunotherapy is published by the Lippincott Williams and Wilkins, with its country of publication being the United States.


What's the current ranking of the Journal of Immunotherapy?

The Journal of Immunotherapy is currently ranked 3530 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1225 in 2015 and its lowest position of 3530 in 2024.


What's the abbreviation or short name for the Journal of Immunotherapy?

The standard ISO4 abbreviation for the Journal of Immunotherapy is J. Immunother..


Is the "Journal of Immunotherapy" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Journal of Immunotherapy is classified as a journal that the Lippincott Williams and Wilkins publishes.


What's the scope or major areas of the Journal of Immunotherapy?

The Journal of Immunotherapy encompasses the following areas:

  • Pharmacology
  • Cancer Research
  • Immunology
  • Immunology and Allergy

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Journal of Immunotherapy?

The Journal of Immunotherapy is assigned the following International Standard Serial Numbers (ISSN): 15249557, 15374513.


What's the best quartile of the Journal of Immunotherapy?

The best quartile for the Journal of Immunotherapy is Q1 (2024).


What's the coverage history of the Journal of Immunotherapy?

The Journal of Immunotherapy coverage history can be summarized as follows: 1991-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Current Sociology journal 5151 SAGE Publications Ltd 86 3.02
Criminal Justice Review journal 10284 SAGE Publications Inc. 46 1.91
Milan Journal of Mathematics journal 5131 Birkhauser Verlag Basel 31 0.74
Materials Research journal 15597 Universidade Federal de Sao Carlos 75 1.40
Sapporo Medical Journal journal 29756 Sapporo Medical University 3 0.00
Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute journal 29148 Hoikkaido Forest Products Research Institute 4 0.00
Biological Procedures Online journal 5232 BioMed Central Ltd 51 4.00
Genes and Nutrition journal 4763 BioMed Central Ltd 69 4.26
Proceedings of the Royal Society of Queensland journal 28017 Royal Society of Queensland 12 0.17
Physica Status Solidi - Rapid Research Letters journal 9522 Wiley-VCH Verlag 83 2.34

Check complete list




Year wise Impact Score (IS) of Journal of Immunotherapy

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 2.78
2023 3.12
2022 3.78
2021 4.63
2020 4.30
2019 4.17
2018 3.64
2017 4.23
2016 4.22
2015 4.20
2014 4.34



Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Immunology

Nature Reviews Immunology
Nature Research | United Kingdom

Annual Review of Immunology
Annual Reviews Inc. | United States

Nature Reviews Microbiology
Nature Research | United Kingdom

Immunity
Cell Press | United States

Nature Immunology
Nature Research | United Kingdom

Science immunology
American Association for the Advancement of Science | United States

Cell Host and Microbe
Cell Press | United States

Nature Microbiology
Nature Research | United Kingdom

Cellular and Molecular Immunology
Springer Nature | United Kingdom

Journal of Experimental Medicine
Rockefeller University Press | United States

See All

Top Journals/Conferences in Immunology and Allergy

Nature Reviews Immunology
Nature Research | United Kingdom

Annual Review of Immunology
Annual Reviews Inc. | United States

Immunity
Cell Press | United States

Nature Immunology
Nature Research | United Kingdom

Science immunology
American Association for the Advancement of Science | United States

Cellular and Molecular Immunology
Springer Nature | United Kingdom

Journal of Experimental Medicine
Rockefeller University Press | United States

Annals of the Rheumatic Diseases
Elsevier B.V. | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Journal of Allergy and Clinical Immunology
Elsevier Inc. | United States

See All